Khadija Saeed

A dedicated markets reporter, she covers stocks, macroeconomics, and major business developments with a sharp eye for detail and accuracy.

PayPal stock slips in late trade as Wall Street wraps 2025; what investors watch next for PYPL

PayPal stock slips in late trade as Wall Street wraps 2025; what investors watch next for PYPL

NEW YORK, Dec 31, 2025, 6:41 PM ET — After-hours PayPal Holdings, Inc. (PYPL) shares were down 1.2% at $58.38 in after-hours trading on Wednesday, when stocks changed hands outside the regular 9:30 a.m. to 4 p.m. ET session. The stock traded between $58.30 and $59.21 and saw about 13.0 million shares in volume, with the shares valued at roughly 13 times trailing earnings, a standard price-to-earnings measure. The move matters now because liquidity typically dries up into the final session of the year, leaving even modest flows to move prices. Investors also use the calendar turn to reset exposure
ServiceNow (NOW) stock slips after hours as CEO contract change nears and $7.75B Armis deal stays in focus

ServiceNow (NOW) stock slips after hours as CEO contract change nears and $7.75B Armis deal stays in focus

NEW YORK, December 31, 2025, 19:07 ET — After-hours ServiceNow shares fell 0.7% to $153.19 in after-hours trading on Wednesday, which takes place outside the regular 9:30 a.m. to 4 p.m. ET session. The stock’s late move followed a downbeat finish for Wall Street on the final trading day of 2025. The S&P 500 fell 0.7% and the Nasdaq dropped 0.8% in thin trading, with technology stocks the biggest drag, while the 10-year Treasury yield rose to 4.17%, AP reported. The Business Journal The timing matters because U.S. stock and bond markets are closed on Thursday for New Year’s Day,
Axsome stock jumps nearly 23% after FDA fast-tracks AXS-05 for Alzheimer’s agitation

Axsome stock jumps nearly 23% after FDA fast-tracks AXS-05 for Alzheimer’s agitation

NEW YORK, December 31, 2025, 19:19 ET — After-hours Axsome Therapeutics, Inc. shares jumped 22.9% to $182.64 in after-hours trading on Wednesday after the company said the U.S. Food and Drug Administration accepted its supplemental New Drug Application for AXS-05 to treat agitation linked to Alzheimer’s disease and granted it Priority Review. The agency set an April 30, 2026 target action date, and CEO Herriot Tabuteau said “up to 76% of people with Alzheimer’s disease experience agitation.” GlobeNewswire The decision matters because Priority Review shortens the FDA’s review timeline, pulling a key regulatory catalyst forward for investors who have been
Bank of America stock today: BAC slips after-hours as year-end selling and rate focus set up January catalysts

Bank of America stock today: BAC slips after-hours as year-end selling and rate focus set up January catalysts

NEW YORK, December 31, 2025, 19:01 ET — After-hours Bank of America shares dipped about 0.5% in after-hours trading on Wednesday, last near $55, after fluctuating between roughly $54.94 and $55.41 during the session. The year-end move matters because markets shut for New Year’s Day, giving investors a pause to reset expectations for rates and bank earnings before trading resumes in 2026. With the next round of big-bank results approaching, even small shifts in Treasury yields can move bank stocks because they influence lending margins and funding costs. In regular trading, Bank of America fell 0.5% to $55.00, alongside declines
Sidus Space stock swings after-hours as $16.2 mln share sale and new 13G stake keep SIDU in focus

Sidus Space stock swings after-hours as $16.2 mln share sale and new 13G stake keep SIDU in focus

NEW YORK, December 31, 2025, 19:07 ET — After-hours Sidus Space Inc shares surged in year-end trading on Wednesday, closing up 31.9% at $3.52 and then sliding about 10.8% in after-hours to $3.14. The Nasdaq-listed stock ranged from $2.48 to $4.20 on the day as volume ran above 168 million shares. Yahoo Finance The sharp move matters because Sidus, like many early-stage space hardware and data companies, relies heavily on access to capital markets. When financing news hits, the stock can swing quickly as investors recalibrate near-term cash runway versus dilution. It also comes at a moment when traders are
Salesforce stock slips after-hours to end 2025 as focus turns to Agentforce AI and Feb. 25 earnings

Salesforce stock slips after-hours to end 2025 as focus turns to Agentforce AI and Feb. 25 earnings

NEW YORK, December 31, 2025, 19:03 ET — After-hours Salesforce, Inc. shares ended down 0.4% on Wednesday and hovered near $264.91 in after-hours trading, as the cloud software maker closed out 2025’s final session on a subdued note. The stock traded between $264.44 and $266.12 during the session. The late drift underscored how thin year-end liquidity can magnify moves in large-cap technology names, even without fresh company news. For Salesforce, the timing matters because investors are resetting exposure ahead of 2026, when spending on enterprise software and new AI features is expected to be under sharper scrutiny. A Yahoo Finance
Pfizer stock dips after-hours as 2026 drug price hike list puts PFE in the spotlight

Pfizer stock dips after-hours as 2026 drug price hike list puts PFE in the spotlight

NEW YORK, December 31, 2025, 18:50 ET — After-hours Pfizer Inc. shares fell about 0.4% to $24.90 in after-hours trading on Wednesday, after a report said the drugmaker is leading a wave of U.S. list-price increases set for 2026. The data, compiled by healthcare research firm 3 Axis Advisors, showed drugmakers plan hikes on at least 350 branded medicines, with Pfizer accounting for around 80 increases, including a 15% rise for its COVID vaccine Comirnaty. “They really just nibble around the margins,” said Dr. Benjamin Rome, a health policy researcher at Brigham and Women’s Hospital in Boston. Reuters The timing
Cisco stock today: CSCO slips into the close as year-end trading thins, dividend date nears

Cisco stock today: CSCO slips into the close as year-end trading thins, dividend date nears

NEW YORK, December 31, 2025, 18:54 ET — After-hours Cisco Systems Inc shares slipped in the final trading session of 2025, closing down about 0.5% at $77.03 and holding steady in after-hours trading. The move came as Wall Street wrapped up the year with broad declines in thin holiday-week trade. The S&P 500 fell 0.74% and the Nasdaq dropped 0.76%, and U.S. markets are closed on Thursday for New Year’s Day, Reuters reported. “It’s perfectly fine in any bull market to have moments of cost,” said Giuseppe Sette, co-founder and president of Reflexivity, pointing to profit-taking when liquidity is low.
GE Vernova stock slips after hours as 2025 ends; dividend date and January earnings in focus

GE Vernova stock slips after hours as 2025 ends; dividend date and January earnings in focus

NEW YORK, December 31, 2025, 18:41 ET — After-hours GE Vernova Inc. shares fell in after-hours trading on Wednesday, down 0.9% at $653.57 by 6:41 p.m. ET, or $6.19 below Tuesday’s close. The stock traded between $647.71 and $666.30 during the day, with about 1.26 million shares changing hands. The slide underscores how sensitive the stock has become to year-end positioning after a sharp run tied to rising electricity demand and data-center buildouts. GE Vernova’s shares have risen more than 370% since the company was spun off from General Electric in 2024, Reuters reported earlier this month. Reuters With U.S.
Corcept stock plunges 50% after FDA rejects relacorilant in Cushing’s-related hypertension

Corcept stock plunges 50% after FDA rejects relacorilant in Cushing’s-related hypertension

NEW YORK, December 31, 2025, 18:31 ET — After-hours Corcept Therapeutics Inc shares sank about 50% in after-hours trading on Wednesday after the U.S. Food and Drug Administration declined to approve its oral drug relacorilant for a Cushing’s-related hypertension use. The stock was last at $34.80, down $35.39 from the prior close. Reuters The decision hits at a key moment for Corcept, which investors have looked to relacorilant to expand the company’s business beyond its marketed drug Korlym. A regulatory setback for relacorilant raises the risk that Corcept’s next growth driver takes longer—and costs more—to reach the market. Reuters Corcept
Super Micro (SMCI) stock slips into year-end after SEC filing flags operations shake-up

Super Micro (SMCI) stock slips into year-end after SEC filing flags operations shake-up

NEW YORK, December 31, 2025, 18:49 ET — After-hours Super Micro Computer shares slid on Wednesday in thin year-end trading, as investors weighed a leadership change disclosed in a regulatory filing and a broader pullback in technology stocks. The move matters because Super Micro’s valuation has remained tightly tied to confidence in execution — shipping high-end server systems on time while managing margins in a competitive AI hardware market. It also lands as the company closes its fiscal second quarter on Dec. 31, setting up a fresh read on demand and delivery cadence when it next updates investors. Super Micro
Goldman Sachs stock slips after hours as Wall Street ends 2025 lower; GS earnings in focus

Goldman Sachs stock slips after hours as Wall Street ends 2025 lower; GS earnings in focus

NEW YORK, December 31, 2025, 18:38 ET — After-hours Goldman Sachs Group Inc (GS) shares fell about 0.6% to $879 in after-hours trading on Wednesday, after trading between $876.75 and $886.26 during the regular session. About 1.2 million shares changed hands. The slide followed a modest year-end drop across U.S. equities as investors trimmed risk ahead of the New Year holiday. For Goldman, a bellwether for trading and dealmaking, attention is already shifting to January’s earnings season. Why it matters now: bank shares tend to react sharply when the outlook for interest rates changes. That is because rates influence loan

Stock Market Today

BAT share price closes near 52-week high as buyback rolls on ahead of results week

BAT share price closes near 52-week high as buyback rolls on ahead of results week

7 February 2026
British American Tobacco shares closed up 1.2% at 4,609 pence Friday, near a 52-week high. The company disclosed further share buybacks and management share purchases ahead of its Feb. 12 full-year results. BAT bought 121,668 shares for cancellation on Feb. 5. Investors await updates on nicotine alternatives and cash returns.
Anglo American share price slips as BofA turns neutral after copper outlook cut

Anglo American share price slips as BofA turns neutral after copper outlook cut

7 February 2026
Anglo American shares closed down 0.75% at 3,435 pence Friday after BofA Global Research downgraded the miner to “neutral” and raised its price target to 3,600 pence. Anglo cut its 2026 copper production guidance and warned of continued weakness at De Beers. The company expects $200 million in charges tied to its Chile copper operations in the second half of 2025.
Amazon’s $200B AI Spending Jolt Spurs Stock Selloff as Big Tech Capex Nears $650B

Amazon’s $200B AI Spending Jolt Spurs Stock Selloff as Big Tech Capex Nears $650B

7 February 2026
Amazon shares fell Friday after the company announced a $200 billion AI infrastructure plan for 2026, exceeding analyst expectations and reviving investor concerns about profitability. Combined 2026 capex flagged by Amazon, Alphabet, Microsoft, and Meta now tops $630 billion. Nvidia, AMD, and Broadcom shares surged on the news, while software and data firms remained under pressure.
Go toTop